Biophysical translational paradigm of polymeric nanoparticle: Embarked advancement to brain tumor therapy

• Published in: Biomedicine & pharmacotherapy Vol. 179; p. 117372
• Main Authors: Naser, Shaikh Sheeran, Gupta, Abha, Choudhury, Anmol, Yadav, Anu, Sinha, Adrija, Kirti, Apoorv, Singh, Deobrat, Kujawska, Małgorzata, Kaushik, Nagendra Kumar, Ghosh, Aishee, De, Sriparna, Verma, Suresh K.
• Format: Journal Article
• Language: English
• Published: France Elsevier Masson SAS 01-10-2024; Elsevier
• Subjects: Blood-brain barrier; Brain tumours; Polymeric Nanoparticle; Theranostics; Blood-brain barrier; Brain tumours; Theranostics; Polymeric Nanoparticle
• ISSN: 0753-3322; 1950-6007; 1950-6007
• DOI: 10.1016/j.biopha.2024.117372

Polymeric nanoparticles have emerged as promising contenders for addressing the intricate challenges encountered in brain tumor therapy due to their distinctive attributes, including adjustable size, biocompatibility, and controlled drug release kinetics. This review comprehensively delves into the latest developments in synthesizing, characterizing, and applying polymeric nanoparticles explicitly tailored for brain tumor therapy. Various synthesis methodologies, such as emulsion polymerization, nanoprecipitation, and template-assisted fabrication, are scrutinized within the context of brain tumor targeting, elucidating their advantages and limitations concerning traversing the blood-brain barrier. Furthermore, strategies pertaining to surface modification and functionalization are expounded upon to augment the stability, biocompatibility, and targeting prowess of polymeric nanoparticles amidst the intricate milieu of the brain microenvironment. Characterization techniques encompassing dynamic light scattering, transmission electron microscopy, and spectroscopic methods are scrutinized to evaluate the physicochemical attributes of polymeric nanoparticles engineered for brain tumor therapy. Moreover, a comprehensive exploration of the manifold applications of polymeric nanoparticles encompassing drug delivery, gene therapy, imaging, and combination therapies for brain tumours is undertaken. Special emphasis is placed on the encapsulation of diverse therapeutics within polymeric nanoparticles, thereby shielding them from degradation and enabling precise targeting within the brain. Additionally, recent advancements in stimuli-responsive and multifunctional polymeric nanoparticles are probed for their potential in personalized medicine and theranostics tailored for brain tumours. In essence, this review furnishes an all-encompassing overview of the recent strides made in tailoring polymeric nanoparticles for brain tumor therapy, illuminating their synthesis, characterization, and multifaceted application.
[Display omitted]
•Polymeric nanoparticles are promising agent for brain tumor therapy.•Polymeric nanoparticles can adjust size, biocompatibility for Brain tumor therapy.•Polymeric nanoparticles can be used controlled drug release.•Characterization, applications and challenges has been highlighted.